BioSpace News Archive

Foundation Medicine, Inc. and Natera, Inc., announced the launch of the research use version of FoundationOne®Tracker, Foundation Medicine’s personalized circulating tumor DNA monitoring assay.

ANANDA Scientific Inc., a biotech pharmaceutical company, and NYU Grossman School of Medicine announced that the first patient has been enrolled in a clinical trial evaluating Nantheia™ A1002N5S, an investigational drug using cannabidiol in ANANDA’s proprietary Liquid Structure™ delivery technology as a treatment for Post-Traumatic Stress Disorder symptoms and Neurocognitive Impairment in patients with PTSD and with PTSD comorbid with Traumatic Brain Injury.

AngioDynamics to Hold Fiscal Fourth Quarter and Fiscal Year 2021 Earnings Conference Call and Virtual Investor and Technology Day on July 13, 2021.

Third Board appointment of 2021 supports long-term vision for the company’s technology platform for 908 Devices.

Kiniksa Pharmaceuticals, Ltd.- Defined regulatory pathway for Phase 3 clinical development of mavrilimumab in multiple indications.

ProMIS Neurosciences, Inc. today congratulates Biogen on the recent FDA approval of its monoclonal antibody therapeutic, aducanumab.

OneThree Biotech today announced a collaboration with Sun Pharma Advanced Research Company Ltd. to enhance understanding of the biological mechanisms driving a key oncologic disease pathway.

ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. announced that the parties anticipate the closing of their previously announced merger to occur promptly after approval of their pending Nasdaq listing application.

Allergan Aesthetics, an AbbVie company, is changing the way BOTOX® Cosmetic, the #1 selling neurotoxin treatment1, is connecting with consumers.

Lux Capital, Mubadala Capital, Obvious Ventures, and DCVC among founding group supporting underrepresented founders building next-generation healthcare companies